SHC

Sotera Health Company

Healthcare · $5.3B market cap

Verdict

Share price

$18.22

close of Oct 3, 2026

Fair value

$14.11

Sticker Price

Payback Price

$5.64

buy price

Overpriced

SHC is Overpriced: at $18.22 it trades 29% above its fair value of $14.11. Its buy price (Payback Price) is $5.64, 69% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow Growth. Reported earnings are shrinking, but free cash flow keeps growing, so we value it on cash flow.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-10.0% a year✗
Equity per share growth3.7% a year✗
Sales growth6.8% a year✗
Free cash flow growth16.0% a year✓
Return on invested capital5.1%✗

Follow SHC

Get notified when it reaches its buy price of $5.64. Free.

Create a free account

Superinvestors

1 of the investors we track holds SHC. Who we track

Insider activity

Since Aug 5, 2026: no open-market purchases, 3 sales worth $24.0M and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Sotera Health Company

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works